1. 国家自然科学基金委员会，面上项目，家族性烟雾病诱导多能干细胞模型构建及其发病机制研究，已结题，主持；

2. 国家自然科学基金委员会, 面上项目, 基于血管化类脑器官探索Wnt通路在RNF213突变烟雾病基底节血管生成中的机制研究, 在研, 主持；

3.北京市教育委员会，科技计划一般项目，环指蛋白213基因突变与颅内大动脉狭窄的相关性研究及机制探讨，已结题，主持；

4.北京市卫生健康委员会, 北京市属医院科研培育计划, 基于多模态磁共振评价他汀类药物治疗缺血型烟雾病的有效性研究, 在研, 主持。

1. Yimeng Xue #, Chaofan Zeng #, Peicong Ge, Chenglong Liu,Junsheng, Yan Zhang, Dong Zhang, Qian Zhang*, Jizong Zhao*. Association ofRNF213 Variants With Periventricular Anastomosis in Moyamoya Disease. Stroke.2022,Online ahead of print.SCI

2. Ge Peicong, Zhang Qian*, Ye Xun, Liu Xingju, DengXiaofeng, Wang Jia, Wang Rong, Zhang Yan, Zhang Dong, Zhao Jizong*.ModifiableRisk Factors Associated With Moyamoya Disease: A Case-Control Study. Stroke.2020,51:2472-2479.SCI

3. Ma Yonggang, Zhao Meng, Deng Xiaofeng, Zhang Dong, WangShuo, Zeng Zheng, Zhang Qian*, Zhao Jizong*.Comparison of clinical outcomes andcharacteristics between patients with and without hypertension in moyamoyadisease. Journal of Clinical Neuroscience. 2020,75:163-167.SCI

4. Zhang Qian, Zhao Meng, Ge Peicong, Liu Xingju, Wang Rong,Zhang Yan, Zhang Dong, * Zhao Jizong*.Hemorrhagic patterns and their riskfactors in patients with moyamoya disease. European Journal of Neurology.2020,27(12):2499-2507.SCI

5. Zhang Qian, Ge Peicong, Ma Yonggang, Zhang Dong, WangRong, Zhang Yan, Wang Shuo, Cao Yong, Zhao Meng, Zhao Jizong*.Clinical Featuresand Surgical Outcomes of Patients With Moyamoya Disease and the HomozygousRNF213 p.R4810K Variant. Journal of Child Neurology. 2019,34(13):793-800.SCI

6. Ge Peicong,Ye Xun, Liu Xingju,Deng Xiaofeng,WangRong,Zhang Yan,Zhang Dong,Zhang Qian*; Zhao Jizong*.Association Betweenp.R4810K Variant and Long-Term Clinical Outcome in Patients With MoyamoyaDisease. Frontiers in Neurology. 2019,10:662.SCI

7. Zhang Qian#, Yu Lebao#, Ge Peicong, Ma Yonggang, ZhangDong, Zhang Yan, Wang Rong, Wang Shuo, Zhao Yuanli, Cao Yong, Liu Xingju, DengXiaofeng, Zhao Jizong*.Association of Ring Finger Protein 213 Gene P.R4810kPolymorphism with Intracranial Major Artery Stenosis/Occlusion. Journal ofStroke & Cerebrovascular Diseases. 2018,27(6):1556-1564.SCI

8. Ge Peicong#, Zhang Qian#, Ye Xun, Wang Shuo, Zhang Dong,Zhao Jizong*.Clinical Features, Surgical Treatment, and Long-Term Outcome inChildren with Hemorrhagic Moyamoya Disease. Journal of Stroke &Cerebrovascular Diseases. 2018,27(6):1517-1523.SCI

9. Zhang Qian#, Si Nuo#, Liu Yaping, Zhang Dong, Wang Rong,Zhang Yan, Wang Shuo, Liu Xingju, Deng Xiaofeng, Ma Yonggang, Ge Peicong, ZhaoJizong*, Zhang Xue*.Steroid sulfatase and filaggrin mutations in a boy withsevere ichthyosis, elevated serum IgE level and moyamoya syndrome. Gene.2017,628:103-108.SCI

10. Zhang Qian#, Liu Yaping#, Yu Lebao, Duan Ran, MaYonggang, Ge Peicong, Zhang Dong, Zhang Yan, Wang Rong, Wang Shuo, Zhao Yuanli,Cao Yong, Liu Xingju, Deng Xiaofeng, Zhao Jizong*, Zhang Xue*.The Associationof the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease and a Review ofthe Pertinent Literature. World Neurosurg. 2017,99:701-708.e1.SCI

11. Zhang Qian#, Liu Yaping#, Zhang Dong, Wang Rong, ZhangYan, Wang Shuo, Yu Lanbing, Lu Chaoxia, Liu Fang, Zhou Jian, Zhang Xue, ZhaoJizong*.RNF213 as the major susceptibility gene for Chinese patients withmoyamoya disease and its clinical relevance. JOURNAL OF NEUROSURGERY.2017,126(4):1106-1113.SCI

12. Zhang Qian#, Zhang Dong#, Wang Rong, Liu Yaping, ZhangYan, Wang Shuo, Zhao Jizong*.Clinical and Angiographic Features of Patientswith Moyamoya Disease and the p.R4810K Heterozygous Variant. World Neurosurg.2016,90:530-538.e3.SCI

13. Zhang Qian#, Wang Rong#, Liu Yaping, Zhang Yan, WangShuo, Cao Yong, Zhao Yuanli, Liu Xingju, Wang Jia, Deng Xiaofeng, Gao Faliang,Yang Ziwen, Zhao Meng, Ge Peicong, Ma Yonggang, Zhao Jizong*, ZhangDong*.Clinical Features and Long-Term Outcomes of Unilateral Moyamoya Disease.World Neurosurg. 2016,96:474-482.SCI

14.张谦; 冀瑞俊; 赵萌; 王文娟; 陆菁菁; 李娜; 刘艳芳; 边立衡; 于嵩林; 李昊; 张倩; 吴建维; 王丹丹; 王晶; 李朝霞; 姜睿璇; 康开江; 薛艺萌; 押小龙; 何蕲恒; 莫少华; 赵性泉; 赵继宗 ; 中国脑血管病临床管理指南（第2版） （节选）——第5章 脑出血临床管理, 中国卒中杂志

15.专利：薛艺萌; 张谦; 赵继宗 ; 一种烟雾病血管类器官模型及其构建方法